PDF herunterladen
Dtsch Med Wochenschr 2004; 129(12): 641-646
DOI: 10.1055/s-2004-820575
Übersichten
Gynäkologie / Endokrinologie
© Georg Thieme Verlag Stuttgart · New York

Mastopathie, Mammakarzinom und Jodlactone

Mastopathy, breast cancer and iodolactoneP. Torremante1
  • 1Gynäkologische Praxis Dr. Torremante
Weitere Informationen

Publikationsverlauf

eingereicht: 23.6.2003

akzeptiert: 7.11.2003

Publikationsdatum:
26. Januar 2005 (online)

Auch verfügbar auf
   Lizenzen und Reprints
Preview

Summary

An enlargement of the thyroid gland is often found in patients with breast cancer and fibrocystic disease. Experimental analysis in animals shows that iodine deficiency causes proliferations and dysplasia in the mammary gland similar to human fibrocystic disease. Elemental iodine supplementation can stop and partially lead to an involution of the mammary proliferations and dysplasia. Probably iodolactones are involved in the process of involution, similar to thyroid gland. The basis for iodolactone production in the mammary gland is given. Like the thyroid gland, the mammary gland can concentrate iodide by expressing the sodium/iodide symporter, the cell membrane transport protein. The sodium/iodide symporter is not only expressed during lactation but also in fibrocystic disease and in the majority of breast cancers. Iodolactones are synthesized with the mammary enzyme lactoperoxidase, an enzyme that is used for the pharmacological synthesis of iodolactones. Iodolactones can inhibit the EGF-receptor, thereby playing an important role in the pathophysiology of breast cancer and fibrocystic disease. Using the sodium/iodide symporter there are new options for the therapy of metastatic breast cancer.

Beitrag in Volltext: https://www.thieme-connect.de/ejournals/html/10.1055/s-2004-820575

Full text article: https://www.thieme-connect.de/ejournals/html/10.1055/s-2004-834453

Literatur

  • 1 Adamopoulos D, Vassilaros S, Kapolla N, Papadiamatis J, Georgiakodis F, Michalakis A. Thyroid disease in patients with benign and malignant mastopathy.  Cancer. 1986;  57 125-128
    Suche in Google Scholar
  • 2 Aquino T I, Eskin B A. Rat breast structure in altered iodine metabolism.  Arch Path. 1972;  94 280-285
    Suche in Google Scholar
  • 3 Boccardo F, Marenghi C, Ghione G, Pepe A, Rubagotti A. Intracystic epidermal growth factor level is predictive of breast cancer risk in women with gross cystic disease of the breast.  Int J Cancer. 2001;  95 260-265
    Suche in Google Scholar
  • 4 Denkert C, Winzer K J, Müller B M. et al . Elevated Expression of Cyclooxygenase-2 Is a Negative Prognostic Factor for Disease Free Survival and Overall Survival in Patients with Breast Carcinoma.  Cancer. 2003;  97 2978-2987
    Suche in Google Scholar
  • 5 Druckmann R, Rohr U D. IGF-1 in gynaecology and obstetrics: update 2002.  Maturitas. 2002;  41 (Suppl 1) 65-83
    Suche in Google Scholar
  • 6 Dugrillon A, Bechtner G, Uedelhoven W M, Weber P C, Gartner R. Evidence that an iodolactone mediates the inhibitory effect of iodide on thyroid cell proliferation but not on adenosine 3’, 5’-monophosphate formation.  Endocrinology. 1990;  127 337-343
    Suche in Google Scholar
  • 7 Dugrillon A, Gärtner R. δ-Iodolactones decrease epidermal growth factor-induced proliferation and inositol-1,4,5-trisphosphate generation in porcine thyroid follicles - a possible mechanism of growth inhibition by iodide.  Eur J Endocrinol. 1995;  132 735-743
    Suche in Google Scholar
  • 8 Dugrillon A, Gärtner R. The role of Iodine and Thyroid Cell Growth.  Thyroidology. 1992;  4 31-36
    Suche in Google Scholar
  • 9 Dugrillon A, Uedelhoven W M, Pisarev M A, Bechtner G, Gartner R. Identification of delta-iodolactone in iodide treated human goiter and its inhibitory effect on proliferation of human thyroid follicles.  Horm Metab Res. 1994;  26 465-469
    Suche in Google Scholar
  • 10 Eskin B A, Parker F J, Bassett J G, George D L. Human breast uptake of radioactive iodine.  Obstet Gynecol. 1974;  44 398-402
    Suche in Google Scholar
  • 11 Eskin B A, Grotkowski C E, Connolly C P, Ghent W R. Different tissue responses for iodine and iodide in rat thyroid and mammary glands.  Biol Trace Elem Res. 1995;  49 9-19
    Suche in Google Scholar
  • 12 Eskin B A, Shuman R, Krouse T, Merion J. Rat mammary gland atypia produced by iodine blockade with perchlorate.  Cancer Research. 1975;  35 2332-2339
    Suche in Google Scholar
  • 13 Eskin B A. Iodine metabolism and breast cancer.  Trans Ny Acad Sci. 1970;  32 911-947
    Suche in Google Scholar
  • 14 Funahashi H, Imai T, Mase T. et al . Seaweed prevents Breast cancer?.  Jpn J Cancer Res. 2001;  92 483-487
    Suche in Google Scholar
  • 15 Funahashi H, Imai T, Tanaka Y. et al . Suppressive effect of iodine on DMBA-induced breast tumor growth in the rat.  J Surgil Oncol. 1996;  61 209-213
    Suche in Google Scholar
  • 16 Funahashi H, Imai T, Tanaka Y. et al . Wakeame seaweed supresses the proliferation of 7,12-Dimethylbenz(a)-anthracene-induced mammary tumors in rats.  Jpn J Cancer Res. 1999;  90 922-927
    Suche in Google Scholar
  • 17 Gärtner R, Dugrillon A, Bechtner G. Evidence that iodolactones are the mediators of growth inhibition by iodine on the thyroid.  Acta Med Austriaca. 1996;  23 47-51
    Suche in Google Scholar
  • 18 Gärtner R, Dugrillon A. Vom Jodmangel zur Struma.  Internist. 1998;  39 566-573
    Suche in Google Scholar
  • 19 Ghent W R, Eskin B A, Low D A, Hill L P. Iodine replacement in fibrocystic disease of the breast.  Can J Surg. 1993;  36 453-460
    Suche in Google Scholar
  • 20 Giani C, Fierabracci P, Bonacci R. et al . Relationship between breast cancer and thyroid disease: Relevance of autoimmune thyroid disorders in breast malignancy.  Clin Endocrinol Metab. 1996;  81 990-994
    Suche in Google Scholar
  • 21 Hammami M M, Bakheet S. Radioiodine breast uptake in non-breastfeeding women: clinical and scintigraphic characteristics.  J Nucl Med. 1996;  37 26-31
    Suche in Google Scholar
  • 22 Hill P, Wynder E L. Comparision of mammary adipose fatty acid composition in Japanese and American breast cancer patients.  Eur J Cancer Clin Oncol. 1987;  23 407-410
    Suche in Google Scholar
  • 23 Kaizer L, Boyd N F, Kriukov V, Tritchler D. Fish consumption and breast cancer: An ecological study.  Nutr Cancer. 1989;  12 61-68
    Suche in Google Scholar
  • 24 Klijn J GM, Berns P MJJ, Schmitz P IM, Foekens J A. The clinical significance of epidermal growth factor receptor ( EGF-R) in human breast cancer: A Review on 5232 patients.  Endocr Rev. 1992;  13 3-17
    Suche in Google Scholar
  • 25 Kogai T, Schultz J J, Johnson L S, Huang M, Brent G A. Retinoic acid induces sodium-iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line.  Proc Natl Acad Sci USA. 2000;  97 8519-8524
    Suche in Google Scholar
  • 26 Köhrle J. Der Natrium-Iodid-Symporter NIS: Funktion, Regulation und klinische Relevanz.  Z Ärztl Fortbild Qual Sich. 1999;  93 (Suppl 1) 17-22
    Suche in Google Scholar
  • 27 Koifam S, Koifam R J. Breast cancer among Ashkenazi Jewish women in Sao Paulo and Porto Alegre, Brazil.  Breast Cancer Res. 2001;  3 270-275
    Suche in Google Scholar
  • 28 Lichtenstein P, Holm V N, Verkasalo P K. et al . Enviromental and heritable factors in the Causation of cancer.  N Engl J Med. 2000;  343 78-85
    Suche in Google Scholar
  • 29 Natarajan R, Esworthy R, Bai W, Gu J L, Wilczynski S, Nadler J. Increased 12-lipoxygenase expression in breast cancer tissues and cells: Regulation by epidermal growth factor.  J Clin Endocrinol Metab. 1997;  82 1790-1798
    Suche in Google Scholar
  • 30 Natarjan R, Nadler J. Role of lipoxygenases in breast cancer.  Front Biosci. 1998;  3 E81-88
    Suche in Google Scholar
  • 31 Nienhaus A, Hensel N, Roscher G. et al . Hormonelle, medizinische und lebensstilbedingte Faktoren und Brustkrebs.  Geburtsh Frauenheilk. 2002;  62 242-249
    Suche in Google Scholar
  • 32 Normanno N, Ciardiello F. EGF-related peptides in the pathophysiology of the mammary gland.  J Mammary Gland Biol Neoplasia. 1997;  2 143-151
    Suche in Google Scholar
  • 33 Pisani P, Parkin D M, Ferley J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden.  Int J Cancer. 1993;  55 891-903
    Suche in Google Scholar
  • 34 Pisarev M A, Krawiec L, Juvenal G J. et al . Studies on the goiter inhibiting action of iodolactones.  Eur J Pharmacol. 1994;  158 33-37
    Suche in Google Scholar
  • 35 Simon D, Koehrle J, Reiners C h. et al . Redifferentiation therapy with retinoids: Therapeutic option for advanced follicular and papillary thyroid carcinoma.  World J Surg. 1998;  22 569-574
    Suche in Google Scholar
  • 36 Smyth P PA, Smith D F, McDermott E WM, Murray M J, Geraghty J G, O’Higgins N J. A direct relationship between thyroid enlargement and breast cancer.  J Clin Endocrinol Metab. 1996;  81 937-941
    Suche in Google Scholar
  • 37 Spitzer E, Zschiesche W, Binas B, Grosse R, Erdmann B. EGF and TGF alpha modulate structural and functional differentiation of the mammary gland from pregnant mice in vitro: Possible role of the arachidonic acid pathway.  J Cell Biochem. 1995;  57 495-508
    Suche in Google Scholar
  • 38 Spitzweg C, Harrington K J, Pinke L A, Vile R G, Morris J C. The sodium iodide symporter and its potential role in cancer therapy.  J Clin Endocrinol Metab. 2001;  86 3327-3335
    Suche in Google Scholar
  • 39 Strum J M. Effect of iodine-deficiency on rat mammary gland.  Virchows Arch B Cell Pathol Incl Mol Pathol. 1979;  30 209-220
    Suche in Google Scholar
  • 40 Tazebay U H, Wapnir I L, Levy O. et al . The mammary gland iodide transporter is expressed during lactation and in breast cancer.  Nat Med. 2000;  6 871-878
    Suche in Google Scholar
  • 41 Turk J, Henderson W R, Klebanoff S J, Hubbard W C. Iodination of arachidonic acid mediated by eosinophil peroxidase, myeloperoxidase and lactoperoxidase.  Biochim Biophys Acta. 1983;  751 189-200
    Suche in Google Scholar

Dr. med. Pompilio Torremante

Marktplatz 29

88416 Ochsenhausen

Telefon: 07352/941736

eMail: dr.torremante@onlinemed.de